LAROTID Drug Patent Profile
✉ Email this page to a colleague
When do Larotid patents expire, and when can generic versions of Larotid launch?
Larotid is a drug marketed by Glaxosmithkline and Us Antibiotics and is included in two NDAs.
The generic ingredient in LAROTID is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Larotid
A generic version of LAROTID was approved as amoxicillin by TEVA on December 22nd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LAROTID?
- What are the global sales for LAROTID?
- What is Average Wholesale Price for LAROTID?
Summary for LAROTID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Patent Applications: | 459 |
| DailyMed Link: | LAROTID at DailyMed |
US Patents and Regulatory Information for LAROTID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 050460-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Us Antibiotics | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 062226-003 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Us Antibiotics | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 062226-004 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
